Who has invested in A-Alpha Bio?

OS Fund are named among the investors backing A-Alpha Bio.

A-Alpha Bio Funding: $51M Raised, Series A (2023)

A-Alpha Bio funding overview

A-Alpha Bio is based in Seattle, WA. A-Alpha Bio has raised $51M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2023. The round record for A-Alpha Bio runs through 2023; nothing later has been disclosed. Investors on record include OS Fund.

A-Alpha Bio at a glance

Total raised: $51M
Latest round: Series A
Latest round date: October 2023
Headquarters: Seattle, WA
Notable investors: OS Fund

Frequently asked about A-Alpha Bio funding

How much has A-Alpha Bio raised?: A-Alpha Bio has raised $51M in total disclosed funding across the rounds on record.
Who has invested in A-Alpha Bio?: OS Fund are named among the investors backing A-Alpha Bio.
What was the latest A-Alpha Bio funding round?: The most recent disclosed round is a Series A, announced in October 2023.
Where is A-Alpha Bio based?: A-Alpha Bio is based in Seattle, WA.
When did A-Alpha Bio last raise?: The last disclosed A-Alpha Bio round closed in October 2023 at Series A.

Every A-Alpha Bio figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Seattle at a similar stage.

A-Alpha Bio Funding: $51M Raised, Series A (2023)

A-Alpha Bio funding overview

A-Alpha Bio at a glance

Frequently asked about A-Alpha Bio funding

Companies related to A-Alpha Bio (19)

Browse related funding lists (5)